Physician profile
Savitha Shastry
NPI 1518174465
$1,951.46
in general payments reported to CMS, 2019-2025
24 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.93 · 2022: $338 · 2023: $341 · 2024: $727 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $272.92 | 2022-2025 | Evenity, Tepezza, Prolia |
| Novo Nordisk INC | $266.65 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $263.30 | 2022-2025 | Minimed 780g |
| Abbott Laboratories | $239.91 | 2022-2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $158.13 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $107.67 | 2024-2025 | |
| Dexcom, INC. | $98.45 | 2023-2024 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $73.24 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $64.57 | 2024-2025 | Omnipod |
| Corcept Therapeutics | $54.73 | 2022-2025 | Korlym |
| Radius Health, INC. | $54.08 | 2024-2025 | Tymlos |
| Neurocrine Biosciences, INC. | $41.10 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.72 | 2022 | |
| Ethicon US, LLC | $28.92 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.26 | 2023 | Jardiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $25.71 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Medtronic Minimed, INC. | $24.93 | 2019 | |
| Xeris Pharmaceuticals, INC. | $23.41 | 2024 | Recorlev |
| Madrigal Pharmaceuticals | $16.90 | 2024 | Resmetirom |
| Soleno Therapeutics, INC. | $16.46 | 2025 | Vykat Xr |
| Almatica Pharma LLC | $15.92 | 2024 | Teriparatide |
| Alexion Pharmaceuticals, INC. | $14.58 | 2024 | Strensiq |
| Cequr Corporation | $13.75 | 2022 | |
| Nevro Corp. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savitha Shastry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.